Phase 3 trial of subcutaneous epcoritamab plus R-CHOP versus R-CHOP in patients (pts) with newly diagnosed diffuse large B-cell lymphoma (DLBCL): EPCORE DLBCL-2.

被引:0
|
作者
Sehn, Laurie Helen
Chamuleau, Martine
Lenz, Georg
Clausen, Michael
Haioun, Corinne
Izutsu, Koji
Davies, Andrew John John
Zhu, Jun
Oki, Toshiko
Szafer-Glusman, Edith
Conlon, Rebekah
Chiou, Hueiyu
Ipe, David
Elliott, Brian
Wu, Jun
Salles, Gilles A.
机构
[1] BC Canc Ctr Lymphoid Canc, Vancouver, BC, Canada
[2] Univ British Columbia, Vancouver, BC, Canada
[3] Vrije Univ, Amsterdam Univ Med Ctr, Amsterdam, Netherlands
[4] Univ Hosp Munster, Munster, Germany
[5] Vejle Hosp, Vejle, Denmark
[6] Hop Henri Mondor, Creteil, France
[7] Natl Canc Ctr, Tokyo, Japan
[8] Univ Southampton, Southampton NIHR Canc Res UK Expt Canc Med, Southampton, Hants, England
[9] Beijing Canc Hosp, Beijing, Peoples R China
[10] AbbVie Inc, N Chicago, IL USA
[11] Genmab, Plainsboro, NJ USA
[12] Mem Sloan Kettering Canc Ctr, New York, NY USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TPS7592
引用
收藏
页数:1
相关论文
共 50 条
  • [41] EPIDEMIOLOGICAL DATA OF VENEZUELAN PATIENTS WITH LYMPHOMA. IMPROVEMENT OF THE OUTCOME OF FOLLICULAR LYMPHOMA (FL) AND DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) WITH R-CHOP VS CHOP
    Mueller, A.
    Morales, M.
    Acquatella, G.
    Torres, M.
    Reboso, C.
    Tovar, E.
    Chiquin, D.
    Villegas, M.
    Soyano, A.
    Guevara, M.
    Noriega, N.
    Croce, N.
    Capote, L.
    HAEMATOLOGICA, 2012, 97 : 672 - 672
  • [42] Final Results of a Phase I/II Trial of Carfilzomib plus R-CHOP for Frontline Treatment of Patients with Non-Germinal Center Diffuse Large B-Cell Lymphoma (DLBCL)
    Hill, Brian T.
    Torka, Pallawi
    Hernandez-Ilizaliturri, Francisco J.
    Dean, Robert M.
    Jagadeesh, Deepa
    Karamlou, Kasra
    Fu, Chieh-Lin
    Winter, Allison
    Krauspe, Ethan
    Zhou, Jonathan
    Brooks, Taylor R.
    Kacar, Merve
    Tomlinson, Ben K.
    Cooper, Brenda W.
    Li, Hong
    Jia, Xuefei
    Chen, Yanwen
    Thomas, Jenna
    Caimi, Paolo F.
    BLOOD, 2023, 142
  • [43] Diffuse Large B-Cell Lymphoma (DLBCL) Patients with Composite Histology Have Improved Early outcome Compared to De Novo DLBCL When Treated with R-CHOP
    Maurer, Matthew J.
    Witzig, Thomas E.
    Macon, William R.
    Syrbu, Sergei I.
    Cerhan, James R.
    Allmer, Cristine
    Johnston, Patrick B.
    Link, Brain K.
    Habermann, Thomas M.
    BLOOD, 2008, 112 (11) : 974 - 974
  • [44] Pharmacokinetic and pharmacodynamic evaluation of a biosimilar rituximab in newly diagnosed diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP (rituximab, cyclophosphamide, adriamycin, vincristine, prednisolone)
    Viswabandya, Auto
    Prashanthi, P. V.
    Raju, C. Nirmala
    Rajsekhar, Reena
    Mathews, Vikram
    Madki, Shivkumar
    Abhayankar, Dhiraj
    Kethireddypally, Rukmini
    George, Biju
    Chandy, Mammen
    Reddy, Cartikeya
    Srivastava, Alok
    BLOOD, 2007, 110 (11) : 194B - 194B
  • [45] Standard R-CHOP Therapy in Follicular Lymphoma and Diffuse Large B-Cell Lymphoma
    Tomita, Naoto
    Takasaki, Hirotaka
    Fujisawa, Shin
    Miyashita, Kazuho
    Ogusa, Eriko
    Kishimoto, Kumiko
    Matsuura, Shiro
    Sakai, Rika
    Koharazawa, Hideyuki
    Yamamoto, Wataru
    Fujimaki, Katsumichi
    Fujita, Hiroyuki
    Yamamoto, Yoshimi
    Taguchi, Jun
    Kuwabara, Hideyuki
    Motomura, Shigeki
    Ishigatsubo, Yoshiaki
    BLOOD, 2011, 118 (21) : 708 - 709
  • [46] Standard R-CHOP Therapy in Follicular Lymphoma and Diffuse Large B-Cell Lymphoma
    Tomita, Naoto
    Takasaki, Hirotaka
    Fujisawa, Shin
    Miyashita, Kazuho
    Ogusa, Eriko
    Kishimoto, Kumiko
    Matsuura, Shiro
    Sakai, Rika
    Koharazawa, Hideyuki
    Yamamoto, Wataru
    Fujimaki, Katsumichi
    Fujita, Hiroyuki
    Ishii, Yoshimi
    Taguchi, Jun
    Kuwabara, Hideyuki
    Motomura, Shigeki
    Ishigatsubo, Yoshiaki
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2013, 53 (02) : 121 - 125
  • [47] Clinical Outcomes of R-CHOP Chemotherapy Alone Compared with R-CHOP Plus Radiotherapy in Patients with Localized, Non-Bulky Diffuse Large B-Cell Lymphoma
    Park, Ji Hyun
    Yoon, Dok Hyun
    Kim, Shin
    Park, Jung Sun
    Lee, Sang-Wook
    Park, Chan-Sik
    Huh, Jooryung
    Kim, Seok Jin
    Chang, Myung Hee
    Eom, Hyeon Seok
    Park, Yong
    Kim, Jin Seok
    Lee, Soon Il
    Kim, Min Kyoung
    Do, Young Rok
    Won, Jong-Ho
    Mun, Yeung-Chul
    Lee, Won Sik
    Kang, Hye Jin
    Kim, Hyo Jung
    Kwon, Jung Hye
    Kim, Jeong-A
    Kwak, Jae-Yong
    Kong, Jee Hyun
    Oh, Sung Yong
    Lee, Sun Ah
    Lee, Jae Hoon
    Park, Eun Kyung
    Bae, Sung Hwa
    Lee, Je-Jung
    Jun, Hyun Jung
    Kim, Yang Soo
    Yun, Hwan-Jung
    Kim, Won Seog
    Suh, Cheolwon
    BLOOD, 2014, 124 (21)
  • [48] The Immunohistochemical Profile and Other Prognostic Factors In Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with R-CHOP
    Castillo, Jorge J.
    Beltran, Brady
    Chung, Joo-Seop
    Ilic, Ivana
    Leppa, Sirpa
    Seki, Ritsuko
    Uccella, Silvia
    Xia, Zu-Guang
    Butera, James N.
    BLOOD, 2010, 116 (21) : 1679 - 1679
  • [49] Genomic profiling in a subgroup analysis of patients (pts) with diffuse large B-cell lymphoma (DLBCL) and extranodal (EN) sites of involvement in the phase 3 Pola-R-CHP versus R-CHOP (POLARIX) study
    Lue, Jennifer Kimberly
    Morschhauser, Franck
    Tilly, Herve
    Lenz, Georg
    Jardin, Fabrice
    Herrera, Alex Francisco
    Sharman, Jeff Porter
    Flowers, Christopher
    Friedberg, Jonathan W.
    Trneny, Marek
    Herbaux, Charles
    Yan, Mark
    Jiang, Yanwen
    Hirata, Jamie
    Batlevi, Connie Lee
    Sahin, Deniz
    Leung, Wilfred
    Harris, Will
    Salles, Gilles A.
    Sehn, Laurie Helen
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [50] The Impact of Trial Eligibility Criteria on Outcomes in a Nationwide Cohort of Newly Diagnosed DLBCL Patients Treated with R-CHOP
    Severinsen, Freja Tang
    Hanstrup, Laura Mors
    Jensen, Rasmus Kuhr
    Maurer, Matthew J.
    Khurana, Arushi
    Jensen, Paw
    Jorgensen, Judit
    Larsen, Thomas Stauffer
    Clausen, Michael Roost
    Poulsen, Christian Bjorn
    Brown, Peter de Nully
    El-Galaly, Tarec Christoffer
    Jakobsen, Lasse H.
    BLOOD, 2021, 138